1. Efficacy of combination tenofovir plus lamivudine versus tenofovir monotherapy in patients with chronic hepatitis B virus. (13th March 2011) Authors: Glyn, F; Gill, U S; Alazawi, W; Ross, V; Kooner, P; Marley, R; Foster, G R; Kennedy, P T F Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-041 Enhanced Monocyte Function and Surface TLR Expression Predict Post-Operative Systemic Inflammatory Response Syndrome in Patients Immediately following Major Hepatic and Pancreatic Resection. (4th June 2013) Authors: Lahiri, R; Wong, J; Bhattacharya, S; Foster, G; Alazawi, W Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-080 Stat2 is a key mediator of acute pancreatitis. (17th June 2017) Authors: Heath, H; Renney, G; Ward, M; Cutillas, P; Kudu, H; Goldin, R; Hutchins, R; Foster, GR; Brohi, K; Alazawi, W Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P93 NFκB activation by TLR agonists is deficient in macrophages lacking STAT2. (6th September 2011) Authors: Alazawi, W; Gamero, A; Heath, H; Smith, P; Jacobs, M; Waters, J; Foster, G R Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PMO-141 Flagellin-induced IL-6 production is selectively impaired in patients with cirrhosis. (28th May 2012) Authors: Alazawi, W; Spyrou, A; Lahiri, R; Waters, J; Foster, G R Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PMO-148 Evaluation of liver fibrosis in young adult patients with chronic hepatitis B virus. (28th May 2012) Authors: Patel, C; Gill, U S; Alazawi, W; Shaw, P; Alstead, E; Kallis, Y; Kooner, P; Marley, R; Naik, S; ChinAleong, J; Goldin, R D; Foster, G R; Kennedy, P T F Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PTH-010 Rises In both White Cell Count and Crp at Day 3 Predict Failure of Treatment with Metronidazole in C.Difficile Infection. (4th June 2013) Authors: Joshi, N M; Kok, K; Alazawi, W; Goodhand, J; Das, S S; Rampton, D S Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PTH-080 Risk Profile For Non-alcoholic Fatty Liver Disease (nafld) In A Paediatric Specialist Care Setting. (9th June 2014) Authors: Tai, FWD; Derwa, Y; Naik, S; Alazawi, W Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PTH-093 One year mortality outcomes of patients with liver cirrhosis admitted to a teaching hospital intensive care unit. (22nd June 2015) Authors: Tai, D; Lewis, H; Derwa, Y; Lillis, A; Reynolds, T; Maitland, K; Hall, D; Alazawi, W; Foster, GR; Hadley, JS Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PTH-102 Stat2 is a key inflammatory molecule in human non-alcoholic fatty liver disease and murine liver injury. (22nd June 2015) Authors: Alazawi, W; Heath, H; Petts, G; Kudu, H; Feakins, R; O'Brien, A; Goldin, R; Foster, GR Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗